Where does Character Biosciences's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Character Biosciences's 2 recorded funding rounds.

Premier Alternatives

Character Biosciences

Jersey City, NJ · Founded 2018 · Privately Held (backing)

Developer of precision medicine designed to transform drug development for progressive, polygenic diseases. Character Biosciences is based in Jersey City, NJ and was founded in 2018. It was valued at $203 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $137 million across 2 recorded rounds; the latest was an $8.9 million early-stage round in Sep 2025.

PMV mark · valuation

$203.0M

Oct 2026

Priced at

its later-stage round

Sep 2025

Total raised

$136.9M

Last round

Early Stage VC

Sep 2025

Cap table — not yet on record

Character Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Character Biosciences with a free account

·The complete investor list: 18 names
·Watch Character Biosciences: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Character Biosciences

Where does Character Biosciences's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Character Biosciences's 2 recorded funding rounds.